NEW DRUG DISCOVERY
Two days before her tryst with Jensen Huang popped, Nvidia’s Kimberly Powell pitched ‘robot hospitals’ to explain why world’s most valuable chipmaker is betting on healthcare
Nvidia's leadership landscape is in upheaval following Jensen Huang's resignation over multiple extramarital affairs. Rumors involving Kimberly Powell and Alice Huang became public prior to his exit, resulting in Kimberly canceling her summit appearance. Colette Kress will serve as interim CEO while the board evaluates candidates for a permanent replacement. This incident has sparked conversations regarding Powell's qualifications for her role within Nvidia.
Jensen Huang quits as CEO of Nvidia: He was once caught getting cosy with Nvidia VP on camera. Who is Kimberly Powell, the second woman he has been linked with?
Nvidia founder Jensen Huang resigned as CEO on Thursday following reports of an affair with Kimberly Powell, the company’s vice president of healthcare. This follows reports that the billionaire was involved in an affair with Alice Huang, a Chinese executive who U.S. intelligence asserted was a spy for Beijing.
Before Nvidia, Kimberly Powell was an engineering intern in radiology tech; How she built an 18-year career in AI healthcare, now in the spotlight after Jensen Huang report
Kimberly Powell did not begin her career in AI drug discovery. She started as an engineering intern, working with radiologists and medical imaging technology. That experience eventually brought her to Nvidia, where she spent 18 years building its healthcare business. Now, a report about her alleged relationship with Jensen Huang has put her in the headlines. But how did she go from working in radiology to becoming one of Nvidia's senior executives?
What will happen to Kimberly Powell after Jensen Huang's resignation from Nvidia?
The resignation of Jensen Huang from Nvidia has cast shadows over Kimberly Powell's position in the company. Allegations arise suggesting that both individuals had extramarital affairs, complicating the narrative. Huang admitted to infidelity but refrained from naming anyone, while Powell, an 18-year Nvidia veteran who heads the healthcare division and supports AI in medicine, faces uncertainty. Nvidia remains silent on her job's future amidst this controversy.
Jensen Huang quits as Nvidia CEO, putting $4 trillion empire in transition
Jensen Huang has resigned as CEO of Nvidia, prompting concerns regarding the company’s future direction. Colette Kress has been appointed as interim CEO while the board searches for a permanent successor. Huang's departure follows controversy related to personal relationships and an investigation into potential foreign intelligence targeting. His hands-on management style has significantly influenced Nvidia's operations over the decades.
Colette Kress for now, but who next? Inside the race to become only the second CEO in Nvidia’s history
As Jensen Huang steps down as Nvidia CEO following two controversies involving his reported relationships with two women, the question is, "who will lead the AI chipmaker next?" Nvidia has named CFO Colette Kress as interim CEO, but who could get the job permanently? From Ian Buck to Rene Haas, several names are now in the succession discussion. Here is the story behind the new race to become only the second CEO in Nvidia’s history.
- Go To Page 1
From medical imaging to AI drug discovery: The 18-year Nvidia career of Kimberly Powell, now in the spotlight after Jensen Huang relationship report
Kimberly Powell joined Nvidia in 2008 to promote its chips for medical imaging. She became vice president of healthcare in 2017 and now oversees technology for medical imaging, life sciences and drug discovery. A New York Times report alleging an intimate relationship with CEO Jensen Huang has shifted attention to her long career and their workplace relationship.
Nvidia CEO crisis: Who is Jay Puri? Longtime Nvidia VP in focus as Jensen Huang faces scrutiny over alleged affairs with Alice Huang and Kimberly Powell
Nvidia CEO replacement Jay Puri: Jay Puri, an Indian-origin executive who spent more than two decades at Nvidia, is drawing attention as CEO Jensen Huang faces reports of a possible board ouster. Puri retired from his executive role in August 2026, but his experience at the chipmaker has brought his career into focus amid leadership uncertainty.
Watch: Jensen Huang’s reported extramarital partner Kimberly Powell walks the show floor in NVIDIA video
During her talk at BIO 2026, Kimberly Powell of NVIDIA showcased exciting advancements in AI and healthcare technology. Yet, the spotlight has shifted as reports of a claimed affair with CEO Jensen Huang emerged, who recently acknowledged his infidelity, impacting his family. Concurrent investigations are exploring links to foreign intelligence, and NVIDIA assures a thorough and transparent approach to these weighty accusations.
Musk wants to hire Jensen Huang: Elon Musk says he would be honoured to recruit Nvidia CEO if board decides to replace him
Musk hiring Jensen Huang: Elon Musk has said he would be honoured to hire Nvidia CEO Jensen Huang if the chipmaker's board removes him. The comment followed reports of two alleged extramarital relationships involving Huang, including one with Nvidia executive Kimberly Powell and another with a Chinese woman suspected by US intelligence officials of spying for China.
Kimberly Powell: What to know about the Nvidia executive and her reported extramarital affair with Jensen Huang who also had a fling with alleged Chinese spy Alice Huang
In a surprising turn of events, Nvidia's CEO Jensen Huang has publicly acknowledged his infidelity after four decades of marriage. This revelation comes amidst reports of a past relationship with Kimberly Powell, an Nvidia executive, as well as troubling allegations involving Alice Huang, a Chinese businesswoman with suspected ties to Chinese intelligence.
Who is Kimberly Powell? Nvidia vice president who had extramarital affair with CEO Jensen Huang allegedly
Kimberly Powell, Nvidia's vice president of healthcare, has been named in a New York Times report alleging that CEO Jensen Huang had an extramarital relationship with her. Powell joined Nvidia in 2008 and now leads its worldwide healthcare business, covering AI, medical imaging, life sciences and drug discovery.
Dario Amodei says AI could make cancer, Alzheimer’s ‘relics of the past’ in less than a decade as Anthropic expands AI-driven drug discovery push
Anthropic is collaborating with several pharmaceutical companies to utilize AI in drug development processes. These partnerships aim to improve the efficiency of drug discovery, addressing complex challenges in medical research. Notable projects include redesigning therapeutic molecules and accelerating antibody designs for various diseases. Anthropic has also initiated its own research on rare childhood muscular dystrophies, targeting potential clinical trials by late 2028.
Quantum could solve AI energy drain, says tech founder
Quantum computers could curb the vast energy demands of artificial intelligence data centres with their ability to run complex calculations, one of the tech's pioneers told AFP. Australian startup Diraq is conducting the first field test worldwide putting a small quantum computer based on a silicon chip in a commercial data centre in Sydney. Diraq's computer installed in Equinix's Sydney data centre has eight quantum bits, or qubits, on a silicon chip.
Wockhardt seeks 14-year data shield for India-made drugs
Mumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for difficult-to-treat infections. In May this year, the company secured approvals from Indian and US drug regulators for a breakthrough drug, Zaynich (cefepime + zidebactam), to treat complicated urinary tract infection, including acute pyelonephritis or severe kidney infections. Wockhardt has showcased six drugs to treat antimicrobial resistance (AMR).
Short-term headwinds, yes; owning the ecosystem is better: 20 healthcare stocks with downside risk of 23% to upside potential of 41%
The healthcare sector is under scrutiny. The issue is pricing: What medicines cost and on what hospitals and the rest of the health ecosystem charge. And both the government and the courts have stepped in. At one level, that is not entirely a bad thing. Check out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focusing on five key components – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. SR+ Reports is a complimentary offering to ETPrime members.
AI is no longer just coding or generating images. It has now designed a virus that was used on a human being. Did the patient survive?
A California startup has used artificial intelligence to design a virus that was administered to a human patient for the first time. The experimental treatment uses bacteriophages to target antibiotic-resistant bacteria, potentially opening a new way to fight infections that conventional medicines cannot control. However, the patient's recovery has not been disclosed.
QClairvoyance's quantum chemistry bet: Transitioning from research to pharma partnerships
QClairvoyance Quantum Labs has performed chemically precise simulations of eight small molecules on an actual quantum computer, marking progress towards drug discovery applications.
Oracle's Larry Ellison dismisses 'SaaS apocalypse' fears, says AI will make software better
Speaking at Oracle AI World here, Ellison, the company's executive chairman and chief technology officer, rejected talk of a "SaaS apocalypse", in which businesses would use AI to build their own applications instead of buying software-as-a-service (SaaS) products.
AI halves drug discovery times, but =trial bottleneck remains a costly reality
Novo Nordisk, Sanofi and Dr Reddy’s Laboratories are among the companies exploring applications ranging from drug discovery to laboratory automation and research.
NYC influencer Wendy Durán arrested in Colombia after cops find cache of guns and drugs in her apartment; all you need to know about her
Wendy Durán, a social media influencer known for her brand expansion content, was arrested in Columbia for illegal firearm possession. During the execution of a search warrant, authorities uncovered two Glocks and a Colt rifle in her home. Although she faces charges for trafficking and carrying firearms, there are no drug possession charges against her. Investigations are ongoing to explore any other potential criminal activities linked to Durán.
Silver dividends: How investing in ageing societies can boost growth and cut healthcare costs
As populations age and people work longer, governments can turn longevity into an economic opportunity by investing in accessible infrastructure, reskilling and flexible employment. The proposed “silver multiplier” captures how keeping older people socially and economically engaged can raise output, support entrepreneurship, improve public health and reduce healthcare spending.
Europe’s last penicillin plant faces a bitter fight against China’s cheaper drugs
The Sandoz penicillin plant in Kundl, Austria, is under threat from cheaper Chinese antibiotic production. European healthcare programs benefit from the lower prices, which could jeopardize self-sufficiency. China's share of the EU penicillins market has rapidly increased in recent years. European policymakers are becoming increasingly concerned about reliance on China for essential medicines. The current dynamics highlight the significant trade challenges facing European pharmaceutical manufacturers.
One decision that made Jensen Huang worth $185 billion: Nvidia nearly went bankrupt in 1996, then a risky bet helped build its AI dominance
Jensen Huang went from working as a dishwasher at Denny’s to becoming the billionaire CEO of Nvidia. The turning point came in 1993, when he cofounded the company with two engineers to develop chips for better computer graphics. After an early setback nearly bankrupted Nvidia, Huang backed graphics-processing technology that later became essential to artificial intelligence, helping transform the company into a global technology powerhouse.
AI rapidly improving, could vastly boost US GDP: Anthropic's Clark tells policymakers
Clark, speaking at IMF and World Bank annual meetings in Bangkok, said that international cooperation was needed to erect "unusual and serious rules" for the transformative technology, and there was a shrinking window for policymakers to act.
Ministry of Science signs MoU with Peptris for collab in AI-based drug discovery and development
The Ministry of Science has entered into a partnership with Peptris Technologies to bolster drug development under the initiative called VIGOR. This venture, which possesses a total estimated budget of Rs 172 crore, aims to leverage artificial intelligence to refine four experimental drugs targeting critical health issues like neuromuscular disorders and diabetes.
Indian pharma's risk aversion holding back innovation: Kiran Mazumdar-Shaw
Biocon chairperson Kiran Mazumdar-Shaw calls for greater use of digital technology to speed up drug development, as industry leaders push for a shift beyond generics.
Our central mission must be patient-centric innovation: JP Nadda
J P Nadda urges industry to take discoveries ‘from bench to bedside’ as the FICCI–Lilly Bharat Life Sciences Award backs its inaugural cohort with ₹7 crore in grants
When nothing is cheap, winners may come from any corner: 19 stocks with downside to upside potential of -28% to plus 22%
Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends on what it chose in the last five or six. So, one name can do wonderfully while the one sitting next to it does very little. Stock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, fundamentals, relative valuation, risk, and price momentum – to generate standardised scores. The simple average of the above-mentioned five component ratings is normally distributed to reach an average score.
Load More
